secwatch.observer — SEC 8-K summary
======================================

Issuer:     Fulgent Genetics, Inc. (FLGT)
CIK:        0001674930
Form:       8-K
Filed at:   2026-05-14T20:27:52+00:00
Accession:  0001193125-26-224147
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Fulgent Genetics shareholders approve 2026 equity plan authorizing 2M new shares
--------------------------------------------------------------------------------

- 2026 Equity Incentive Plan replaces prior 2016 plan; authorizes 2,000,000 new shares plus up to 1,500,000 from forfeited awards.
- All four director nominees elected: Ming Hsieh, Linda Dong, Michael Nohaile, Regina Groves (each to serve until 2027 annual meeting).
- Ratification of Deloitte & Touche LLP as independent auditor for fiscal year 2026 approved (24.5M for, 87K against).
- Non-binding advisory vote on named executive officer compensation passed (19.8M for, 2.4M against, 45K abstain).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1674930/000119312526224147/0001193125-26-224147-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1674930/000119312526224147/flgt-20260514.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-224147

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer